Mapping and Ablation of Frequent Post-Infarction Premature Ventricular Complexes by Sarrazin, Jean-Francois et al.
1002
Mapping and Ablation of Frequent Post-Infarction Premature
Ventricular Complexes
JEAN-FRANCOIS SARRAZIN, M.D., ERIC GOOD, D.O., MICHAEL KUHNE, M.D.,
HAKAN ORAL, M.D., FRANK PELOSI, Jr, M.D., AMAN CHUGH, M.D.,
KRIT JONGNARANGSIN, M.D., THOMAS CRAWFORD, M.D.,
MATTHEW EBINGER, D.O., FRED MORADY, M.D., and FRANK BOGUN, M.D.
From the Department of Cardiology, University of Michigan Cardiovascular Center, Ann Arbor, Michigan, USA
Mapping of Post-Infarction PVCs. Introduction: Premature ventricular complexes (PVCs) occur
frequently in patients with heart disease. The sites of origin of PVCs in patients with prior myocardial
infarction and the response to catheter ablation have not been systematically assessed.
Methods and Results: In 28 consecutive patients (24 men, age 60 ± 10, ejection fraction [EF] 0.37 ± 0.14)
with remote myocardial infarction referred for catheter ablation of symptomatic refractory PVCs, the
PVCs were mapped by activation mapping or pace mapping using an irrigated-tip catheter in conjunction
with an electroanatomic mapping system. The site of origin (SOO) was classified as being within low-voltage
(scar) tissue (amplitude ≤1.5 mV) or tissue with preserved voltage (>1.5 mV). The SOO was confined to
endocardial scar tissue in 24/28 patients (86%). The SOO was outside of scar in 3 patients and could not be
identified in 1 patient. At the SOO, local endocardial activation preceded the PVC by 46 ± 19 ms, and the
electrogram amplitude during sinus rhythm was 0.48 ± 0.34 mV. The PVCs were effectively ablated in 25/28
patients (89%), resulting in a decrease in PVC burden on a 24-hour Holter monitor from 15.6 ± 12.3%
to 2.4 ± 4.2% (P < 0.001). The SOO most often was confined to scar tissue located in the left ventricular
septum and the papillary muscles.
Conclusion: Similar to post-infarction ventricular tachycardia, PVCs after remote myocardial infarction
most often originate within scar tissue. Catheter ablation of these PVCs has a high-success rate. (J Cardiovasc
Electrophysiol, Vol. 21, pp. 1002-1008, September 2010)
catheter ablation, myocardial infarction, premature ventricular complexes, electroanatomic mapping, antiar-
rhythmic drugs
Introduction
Catheter ablation of frequent premature ventricular com-
plexes (PVCs) has a high-success rate in patients without
structural heart disease.1 Only a few case reports have de-
scribed mapping and ablation of post-infarction PVCs.2,3
In a small series of post-infarction patients, the impact of
radiofrequency ablation of frequent PVCs on left ventric-
ular ejection fraction (LVEF) was described.4 The purpose
of the study was to describe mapping and ablation of post-
infarction PVCs in a larger series of consecutive patients.
Twenty-one patients were included in previously published
reports.3,4
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Methods
Characteristics of Subjects (Table 1)
Twenty-eight consecutive patients (24 men, mean age
60 ± 10 years, mean LVEF 0.37 ± 0.14) referred for catheter
ablation of symptomatic post-infarction PVCs, refractory to
medical therapy (including β-blocker and/or antiarrhythmic
agents), were analyzed. All patients had remote myocardial
infarctions (MI; mean infarct age 9 ± 6 years). It was an-
terior in 7 patients, inferior in 18 patients, septal in 1 pa-
tient, and lateral in 2 patients. All patients had an ischemic
work-up prior to the ablation. Fifteen patients were treated
with antiarrhythmic drugs before the procedure, either for
ventricular tachycardia (VT) (n = 12) or refractory PVCs
(n = 3). Five patients were on 2 antiarrhythmic drugs simul-
taneously. Thirteen patients had an implantable cardioverter
defibrillator (ICD) implanted before the mapping procedure.
PVC Burden
The PVC burden (i.e., the percentage of all QRS com-
plexes that were PVCs) was measured with a 24-hour Holter
monitor performed before and 3 months after the abla-
tion procedure, if possible with a 12-lead recording sys-
tem. Eight patients had only one PVC morphology and 20
patients had pleomorphic PVCs. In patients with pleomor-
phic PVCs, the predominant PVC was a PVC accounting for
>50% of the occurring PVCs based on the Holter analysis.
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TABLE 1
Patient Characteristics
Age (years) 60 ± 10
Sex, n (male/female) 24/4
Percutaneous coronary intervention (%) 16 (57)
Coronary artery bypass grafting (%) 13 (46)
Left ventricular ejection fraction 0.37 ± 0.14
History of ventricular tachycardia (%) 17 (61)
Medication
β-Blocker (%) 21 (75)
ACE inhibitor (%) 22 (79)






A 12-lead electrocardiogram (ECG) with the predominant
PVC morphology was obtained prior to the intervention
or at the beginning of the procedure but prior to catheter
insertion.
Evaluation of Left Ventricular Ejection Fraction
All patients had a baseline echocardiogram performed
before the ablation. The LVEF was calculated by the Simpson
formula when 2 consecutive sinus beats were present, using
the second sinus beat for analysis of the LVEF to avoid
post-extrasystolic potentiation of left ventricular function.
A repeat echocardiogram was performed early post-ablation
in all patients (mean 83 ± 96 days; median 67 days) and
at a later time post-ablation in 13 patients (mean 10.4 ±
7.9 months).
Electrophysiology Study
The institutional review committee at the University of
Michigan approved the protocol. The electrophysiology pro-
cedures were performed in the fasting state after informed
consent was obtained. A quadripolar electrode catheter was
advanced via a femoral vein to the right ventricular apex.
Programmed ventricular stimulation was performed with up
to 4 extrastimuli at 3 basic drive cycle lengths to determine
the inducibility of sustained VT.5 VTs were targeted for ab-
lation only if they remained inducible after the PVCs were
ablated. Left ventricular access was obtained with a retro-
grade aortic approach. A bolus of 5,000 units of heparin was
administered followed by an infusion of 1,000 units/hour
to maintain an activated clotting time of approximately 300
seconds. Bipolar electrograms were filtered at 50–500 Hz.
ECG leads and intracardiac electrograms were displayed on
an oscilloscope. The recordings were stored on optical disc
(EP Medical Systems, New Berlin, NY, USA).
Mapping and Ablation
An electroanatomical mapping system (CARTO,
Biosense Webster, Diamond Bar, CA, USA) was used to
create a left ventricular voltage map during sinus rhythm.
In patients with pleomorphic PVCs, only the predominant
PVCs were mapped and ablated during the procedure. PVCs
occurring frequently (bigeminal to quadrigeminal patterns)
were mapped with activation mapping. If the ectopy remained
sporadic (i.e., not in repetitive pattern), pace-mapping was
Figure 1. Twelve-lead ECG tracing showing 2 sinus rhythm beats followed
by a premature ventricular complex (PVC). The recording from the mapping
catheter (MAP) indicates the earliest endocardial activation time at the
effective ablation site of the PVC (arrow).
performed at a pacing cycle length that matched the cou-
pling interval of the spontaneous ventricular ectopy.6 Map-
ping and ablation was performed with a 3.5-mm irrigated-tip
catheter (ThermoCool, Biosense Webster). The earliest ac-
tivation time of the PVCs was recorded (Fig. 1). The local
bipolar amplitude at the effective ablation site was recorded
during sinus rhythm. The presence of isolated potentials, de-
fined as potentials separated from the ventricular electrogram
by an isoelectric segment of more than 20 ms, was also noted.
Bipolar pacing was performed with the distal electrode pair
of the catheter (1-mm inter-electrode space from the ring
electrode).
The sites of origin (SOO) of the PVCs were classified as
being within a region of low voltage (low voltage was defined
as a bipolar voltage amplitude ≤1.5 mV; this was referred
in the manuscript as scar) or a region of preserved voltage
(>1.5 mV). In addition, the region of low voltage was further
separated either in dense scar (<0.5 mV) or in border zone
(0.5–1.5 mV). The anatomic SOO of each targeted PVC was
documented in conjunction with the activation time and the
electrogram amplitude during sinus rhythm at the effective
ablation site.
The power of the radiofrequency energy applications was
titrated upwards to a maximum of 50 W to achieve an
impedance drop of 10 . In the event of pleomorphic PVCs
(present in 20 patients), the predominant PVC morpholo-
gies were targeted. Programmed ventricular stimulation was
repeated at the end of the procedure.
Follow-Up
Antiarrhythmic drug therapy was discontinued if the ab-
lation procedure was effective. In patients who also had VT,
antiarrhythmic medication that was ineffective prior to the
ablation procedure was continued post procedure at the same
dosage. This included amiodarone in 3 patients. No new med-
ications were started. The patients were seen in an arrhythmia
clinic or ICD clinic every 3–6 months during follow-up.
A 24-hour Holter monitor was repeated at 3–6 months
after the ablation procedure to reassess the PVC burden. A
successful outcome was defined as ≥80% reduction in PVC
burden.
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TABLE 2
PVC Characteristics for Each Patient
PVC Pre- # PVC (# PVCs PVC Post- Follow-up
Patients RFA (%) Targeted) SOO SOO Scar Success RFA (%) (Months)
1 43.5 1 (1) Basal LVOT S Y 3.2 3.0
2 38.3 13 (5) PAP anterior + CVS × 3 + septum S × 1 Y 16.7 3.5
3 33.3 6 (2) Left aortic cusp + basal LVOT B × 1 Y 1.0 3.5
4 32.3 1 (1) PAP anterior S Y 0.7 29.5
5 32.0 1 (1) Mitral annulus B Y 0.5 19.0
6 30.0 8 (3) PAP anterior × 2 + para-Hisian S × 2 Y 0.4 12.5
7 27.0 6 (1) Basal LVOT B Y 0.0 4.0
8 24.3 5 (2) Inferior + MA B × 1 Y 0.2 2.0
9 18.0 1 (1) Antero-lateral basal B Y 0.0 28.0
10 15.9 4 (2) Antero-basal × 2 S × 2 N 3.0 23.5
11 15.5 6 (2) Inferior × 2 B × 2 Y 11.4 3.0
12 14.2 1 (1) PAP posterior S Y 0.1 24.0
13 14.1 2 (1) Basal LVOT S Y 0.3 9.0
14 13.9 2 (1) Septum S Y 0.2 23.0
15 13.3 1 (1) PAP posterior B Y 11.8 3.0
16 11.7 10 (5) Septum × 5 B × 3 S × 2 Y 3.3 11.0
17 11.0 2 (1) CVS N Y 2.0 2.5
18 10.3 2 (2) PAP anterior × 2 S × 2 Y 1.2 7.0
19 7.0 1 (1) Left posterior fascicle S Y 1.0 17.0
20 6.0 8 (1) CVS N Y 0.0 13.0
21 6.0 5 (1) Unable to locate N N 6.0 28.0
22 5.3 5 (1) Inferior S Y 0.7 18.0
23 5.0 2 (1) Septum B Y 0.2 20.0
24 5.0 5 (1) Septum S Y 2.0 17.0
25 3.0 1 (1) Intramural B Y 0.0 16.0
26 0.3 3 (1) Intramural N N 0.2 16.5
27 0.2 2 (2) PAP posterior × 2 S × 2 Y 0.0 21.5
28 0.2 4 (1) Inferior S Y 0.0 8.0
Average or total 15.6 108 (44) 33 25 (89%) 2.4 13.8
B = border zone; CVS = coronary venous system; LVOT = left ventricular outflow tract; MA = mitral annulus; N = no; PAP = papillary muscle;
PVC = premature ventricular contractions; RFA = radiofrequency ablation; S = dense scar; SOO = site of origin; Y = yes.
Statistical Analysis
Continuous variables are expressed as the mean ± 1 stan-
dard deviation and were compared using paired Student’s
t test. A P value of <0.05 was considered significant.
Results
Mapping and Origin of PVCs (Table 2)
A total of 108 different PVCs were recorded during the
ablation procedures, with a mean of 3.9 PVCs/patient (me-
dian 2.5 PVCs/patient). Forty-four morphologies of PVCs
were mapped (41%; mean 1.6 PVCs/patient; median 1.0
PVC/patient). The mapped PVCs accounted for 86% of the
total PVC burden in these patients. The average PVC cou-
pling interval was 578 ± 114 ms. The PVC morphologies
were right bundle branch block and superior axis in 13 cases,
right bundle branch block and inferior axis in 20, left bundle
branch block and superior axis in 4, and left bundle branch
block and inferior axis in 7.
The SOO of the predominant PVC was identified in 27
of 28 patients (96%), by activation mapping in 13 patients,
by pace-mapping in 6 patients, and by both techniques in
9 patients. The SOO was within endocardial scar in 24 of
28 patients (86%), accounting for 33 of 44 PVCs (75%).
From these 33 PVCs, 13 (39%) were located in the border
zone and 20 (61%) within the dense scar. In patients with
remote inferolateral MI (n = 19), 28 PVCs were targeted
and 21/28 PVCs (75%) were located within the inferior scar
(inferoseptal = 10, inferior = 5, papillary muscle = 4, and
posterolateral = 1). The remaining PVCs originated from the
epicardium (n = 4), the left ventricular outflow tract (LVOT;
n = 1), the aortomitral continuity (n = 1), and the aortic
cusp (n = 1). One PVC could not be located. In patients
with a prior anteroseptal and lateral MI (n = 9), 16 PVCs
were targeted and 12/16 PVCs (75%) were located within
the anterior scar (papillary muscle = 6, LVOT = 3, and an-
terior = 2). The remaining PVCs originated from the aortic
cusp (n = 2) or the conduction system (His bundle = 1 and
left posterior fascicle = 1). The SOO was in a region of pre-
served voltage in 3 of 28 patients and could not be identified
in 1 patient. Overall, the SOO of the mapped PVCs were
at left ventricular septum (n = 12), the papillary muscle
(n = 10), the LVOT or aortic cusp (n = 7), the epicardium
(n = 5), the inferior wall (n = 5), the anterolateral wall
(n = 3), and the aortomitral continuity (n = 1). The epi-
cardial SOO was reached from the greater cardiac vein in 3
patients. The anatomical distribution of the SOO is shown in
Figure 2, and the different PVC morphologies in Figures 3
and 4.
The SOO was located an average of 19 ± 16 mm from
the border of left ventricular scar (Fig. 5). At the SOO, local
endocardial activation preceded the PVC by an average of
46 ± 19 ms, and the mean electrogram amplitude during
baseline rhythm was 0.48 ± 0.34 mV. Isolated potentials
during sinus rhythm were found in 12 patients at the SOO.
The mean stimulus-to-QRS interval during pace-mapping
was 56 ± 16 ms.
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Figure 2. Anatomical distribution of the premature ventricular complex
(PVC) sites of origin (SOO). Each black dot represents an endocardial PVC
SOO and each gray dot represents an epicardial PVC SOO. PAP = papillary
muscle; LVOT = left ventricular outflow tract.
Pleomorphic PVCs
In 9 of 20 patients with pleomorphic PVCs, two or more
morphologies of PVCs were targeted during the same pro-
cedure. The maximum number of PVCs targeted during the
same procedure was 5. Overall, 41% of the total PVCs were
targeted. Targeted PVCs originated from the same area in
8 of 9 patients. The average distance between the SOO of
the predominant PVC and the SOO of the other PVCs was
27 ± 16 mm.
Figure 3. Nine different premature ventricular complex (PVC) morphologies (named A to I) on 12-lead ECG from several patients are incorporated into a
flow chart based on their intracardiac location.
PVC Ablation and Complications
Forty of 44 targeted PVCs (91%) were ablated acutely in
25 of 28 patients (89%). An average of 13 ± 14 radiofre-
quency energy applications was required for ablation of the
predominant PVC. The average duration of radiofrequency
was 19.7 ± 15.9 minutes. The average procedure time was
309 ± 101 minutes, with a fluoroscopy time of 60 ± 24
minutes.
Fifteen patients (54%) had a total of 46 inducible sustained
VTs. Sixteen of the 46 VTs were reproducibly inducible.
After ablation of 16 PVCs, 9 VTs remained inducible and
were targeted subsequently.
Two complications occurred. The first was 2:1 atrioven-
tricular block with a new left bundle branch block during
ablation near the left posterior fascicle in a patient with preex-
isting right bundle branch block and prolonged HV interval.
This patient already had an ICD and also had interfascicular
VT. The second complication was a femoral arteriovenous
fistula managed conservatively.
Follow-Up
No patients died during a mean follow-up period of
13.8 ± 8.9 months (median 14.5 months). Repeat Holter
monitoring (performed at a mean of 56 ± 36 days post-
ablation) demonstrated a significant decrease in the PVC
burden from 15.6 ± 12.3 to 2.4 ± 4.2% (P < 0.001). The
success rate at 3–6 months post-PVC ablation was 75%. The
PVC burden on repeat Holter monitoring was 2.1 ± 4.0%
for patients with monomorphic PVC, 2.4 ± 4.3% for pa-
tients with pleomorphic PVCs, and 4.1 ± 5.9% for patients
who had 2 or more PVCs targeted during the procedure
1006 Journal of Cardiovascular Electrophysiology Vol. 21, No. 9, September 2010
Figure 4. Same premature ventricu-
lar complex morphologies (A to I) as
Figure 3 with their respective site of ori-
gin in relationship to fluoroscopic im-
ages: A = LAO view and B = RAO view.
CS = multipolar catheter in great car-
diac vein; RA = catheter in the right
atrium; RV = catheter in the right ventri-
cle. The left ventricular cavity is schemat-
ically displayed in red.
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Figure 5. Electroanatomic voltage map of the left ventricle with a septal
scar. The premature ventricular complex originated from the center of the
scar (blue dot and arrow).
(P = ns). Ten out of 15 patients with inducible VT had
less than 1% PVC burden and no VT during the follow-up.
There was a small increase in the mean LVEF early
post-ablation (from 0.37 ± 0.14 to 0.39 ± 0.13; P = 0.2).
The difference became significant with longer follow-up
(0.37 ± 0.14 prior to ablation to 0.43 ± 0.15; P = 0.03).
Discussion
In the majority of patients with remote MI and frequent
PVCs, the PVCs originate at sites of low voltage. Map-
ping and ablation of post-infarction PVCs can be performed
endocardially with a high-success rate. The most common
sites of origin are the left ventricular septum and a papillary
muscle.
Mapping and Origin of Post-Infarction PVCs
There are only a few case reports of successful PVC abla-
tion in patients with ischemic heart disease.2,3 In this series
of consecutive patients with prior MI, PVCs were systemati-
cally mapped and ablated. The SOO of most PVCs was in the
left ventricular endocardium. Furthermore, in most patients,
the effective ablation sites were confined to sites of low volt-
age corresponding with the infarct location. In several of the
patients, the scar tissue gave rise to multiple PVCs that were
mapped and ablated. Voltage mapping in these patients was
helpful in focusing the mapping procedure to the low-voltage
areas, since this area contained the arrhythmogenic substrate
in most patients. In a minority of patients, the SOO of the
mapped PVCs was at a site of normal voltage, similar to the
SOO of idiopathic PVCs.
Similarities with VT Ablation
PVCs in patients with remote MI have several aspects
in common with post-infarction VT. With both types of ar-
rhythmias, critical target sites are within areas of low voltage.
Isolated potentials are frequently present at effective ablation
sites of VT and PVCs.3,7 Furthermore, as demonstrated in a
prior study, post-infarction PVCs and VT often share criti-
cal areas, and mapping and ablation of frequent PVCs can
eliminate VT in these patients.3
Therefore, it is not unexpected that PVCs in patients with
ischemic cardiomyopathy originate mainly from scar tis-
sue in approximately 85% of patients, similar to patients
with ischemic VT. Verma et al. demonstrated that hemo-
dynamically stable ischemic VTs originate mainly from the
scar border area.8 In our study, PVCs originated near the
limit of the dense scar area and the border zone as demon-
strated by a mean electrogram amplitude in sinus rhythm of
0.48 ± 0.34 mV. In another study, a human histopathology
analysis confirmed the correlation between the voltage map
from an electroanatomic map and the scar tissue found on au-
topsy.9 Dense scar correlated with transmural fibrosis, while
the border zone had intermediate fibrosis. Low-voltage ar-
eas on the endocardium serve as the arrhythmia substrate for
most patients with ventricular arrhythmias in the setting of is-
chemic heart disease.10 Adjustment of the voltage color range
can be helpful in order to limit the zone of pace-mapping in
patients with infrequent PVCs.
Mechanisms of PVC
Most PVCs originated from scar tissue. Possible mech-
anisms include reentry, triggered activity, or abnormal
automaticity. Because of several features in common with
post-infarction VT,3 reentry might play a principal role in
post-infarction PVCs. High-resolution mapping might be
required to prove that reentry is the mechanism of post-
infarction PVCs. PVCs that did not originate from scar tissue
could be due to triggered activity or abnormal automaticity,
similar to idiopathic PVCs.
PVC Ablation and LVEF
The mean LVEF improved post-PVC ablation, as in a
previous publication,4 partially explained by overlap in the
patient’s populations. However, the difference occurred later
during follow-up. This may be explained by the larger num-
ber of patients with inducible VT, who may have had a higher
scar burden.
Limitations
In patients with pleomorphic PVCs, the SOO was not
identified for all PVCs, and it is possible that some of the
PVCs originated from sites other than the ones described
in this study. Unipolar recordings were not systematically
used in this study but they could have helped to identify the
site of origin. PVC burden was assessed by 24-hour Holter
monitoring before and after the ablation. Because of the short
period of recording, it is possible that the PVC burden has
been underestimated during the follow-up.
Conclusion
Similar to post-infarction VT, PVCs in patient with is-
chemic cardiomyopathy and remote MI most often originate
at endocardial sites with low voltage. Catheter ablation can
be performed safely and with a high-success rate.
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